The Food and Drug Administration is warning diabetes patients that certain blood sugar tests can give inaccurate results in patients taking other medications.
Public health regulators told consumers not to use certain glucose testing strips from Roche, Abbott Laboratories and other companies in combination with dialysis and other biologic drugs.
According to FDA, those formulations can falsely elevate blood sugar level results, raising the risk of insulin overdose.
People with the disease often have to inject insulin, which helps break down carbohydrates, because their bodies have become resistant to the protein.
Brands affected by the action include Roche's Accu-Chek Comfort Curve strips and Abbott's Freestyle test strips.
Reporting adverse reactions:
Consumers may report adverse reactions related to glucose meters or glucose test strips to FDA’s MedWatch Adverse Event Reporting Program online, by phone, FAX or mail.
Online: MedWatch: The FDA Safety Information and Adverse Event Reporting Program
Mail: use postage-paid FDA form 3500 mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787
A new line of caffeinated chewing gum is causing jitters among health advocates and prompting federal officials to take a new look at the proliferation of jolt-infused foods, including those marketed to children and teens.
Stress, the slowing of metabolism of middle age, and hormone changes after having a baby are three main reasons why many people see the numbers on the scale going up. Dr. Mehmet Oz shares tips on how to shed those final 10 pounds.